Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase NA 3

Status

Completed 4Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1

Conditions

Infections 2Wound Infection 1Surgical Wound Infection 1Laryngeal Neoplasms 1Bone Neoplasms 1

Interventions

Cyclophosphamide 299Cisplatin 298Paclitaxel 257Radiotherapy 255Fluorouracil 234Carboplatin 234Docetaxel 230Doxorubicin 216Dexamethasone 166Gemcitabine 156Vincristine 147Etoposide 136Leucovorin 133Capecitabine 129Bevacizumab 129Prednisone 125Rituximab 118Methotrexate 118Cytarabine 110Filgrastim 99Trastuzumab 97Oxaliplatin 96pembrolizumab 83Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Daunorubicin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Completed × Cefazolin × Clear all
NCT01479283 2021-03-11

PARITY

McMaster University

Phase 3 Completed
602 enrolled
Sarcoma

Bone Neoplasms, Infections

NCT01558986 2012-03-20

Routine Preoperative Antibiotic Prophylaxis in Modified Radical Mastectomy

University of the Philippines

Phase 3 Completed
254 enrolled

Surgical Wound Infection

NCT00867295 2010-06-02

TIVAD

Istanbul University

Phase 3 Completed
150 enrolled

Infections

NCT00467948 2007-05-01

Comparison of 2 Cefazolin Prophylactic Protocol in Laryngectomy Patients

Tehran University of Medical Sciences

Phase 3 Completed
90 enrolled
Head & Neck

Laryngeal Neoplasms, Wound Infection

Data powered by HemOnc (CC BY 4.0) Colophon âš¡